ライブラリ登録: Guest
International Journal of Medicinal Mushrooms

年間 12 号発行

ISSN 印刷: 1521-9437

ISSN オンライン: 1940-4344

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 1.2 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 1.4 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.3 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00066 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.34 SJR: 0.274 SNIP: 0.41 CiteScore™:: 2.8 H-Index: 37

Indexed in

Dietary Supplements from Medicinal Mushrooms: Diversity of Types and Variety of Regulations

巻 2, 発行 1, 2000, 19 pages
DOI: 10.1615/IntJMedMushr.v2.i1.10
Get accessGet access

要約

Many pharmaceutical substances with potent and unique health-enhancing properties were isolated recently from medicinal mushrooms and distributed worldwide. Many of them are not strictly pharmaceutical products ("real" medicines), but rather represent a novel class of dietary supplements (DSs) or "nutriceuticals." They are also known as functional or designer foods, nutraceuticals, phytochemicals, mycochemicals, and biochemopreventatives. Mushroom-based DSs are products from either the mycelia or the fruiting bodies of mushrooms, and are consumed in the form of capsules, tablets, or extracts, and have potential therapeutic effects. We describe here the diversity of different DSs available today on a world market. Most of mushroom products of that sort are dried powders and extracts from naturally growing or commercially cultivated mushroom fruiting bodies, or dried or extracted biomass of mycelium grown in a solid state or in submerged culture. The clear advantages of using mushroom-based DSs in regard to safety (as opposed to herbal preparations) are: (1) The overwhelming majority of mushrooms used for production of DSs are cultivated commercially (and not gathered in the wild). This provides very good chances of proper identification, and for pure and unadulterated products. In many cases it also means genetic uniformity. (2) Mushrooms are easily propagated vegetatively, and thus keep to one clone. The mycelium can be stored for a long time, and the genetic and biochemical consistency may be checked after a considerable period of time. (3) The main advantage, in our opinion, is that many mushrooms that cannot produce fruiting bodies artificially are capable of growing in the form of mycelial biomass in submerged cultures. The problem is that DSs made from mushrooms are highly diverse, and there are currently no standard protocols for ensuring their product quality. There is a serious need for critical analysis, improved quality and legal control, which are essential both to increasing and maintaining consumer confidence, and to meeting the current and future standards set by the regulatory authorities. The usual criticism of DSs concerns standardization, that is, preparing herbs or mushrooms in a way that ensures the consistency and predictability of chemical composition and minimizes the deviations between different batches. This depends on numerous factors including cultivation conditions, composition of substrates, purity of ingredients, stability of active compounds, storage, etc. The regulations of DSs from herbs and mushrooms in a number of major industrial countries are analyzed. In 1991, the World Health Organization (WHO) published its "Guidelines for the assessment of herbal medicines." Regulatory steps taken by most developed countries are usually in accordance with those guidelines of the WHO. The present regulations of the United States [carried out by the Federal Food and Drug Administration (FDA)] treat DS as a separate entity. After passage of the Dietary Supplements Health and Education Act of 1994, the FDA has issued a number of regulations that do not require the manufacturers of DSs to prove their effects and safety in very lengthy and expensive procedures of drug approval. On January 6,2000, the FDA issued its final regulations on structure/function (SF) claims for DS under the DSHEA of 1994. In these rules, a significant shift is made in relation to SF claims for over-the-counter drugs, including DS. In particular, the FDA has enlarged the range of SF claims by agreeing with the comments of the American Herbal

によって引用された
  1. Thompson Iain J, Oyston Petra CF, Williamson Diane E, Potential of the β-glucans to enhance innate resistance to biological agents, Expert Review of Anti-infective Therapy, 8, 3, 2010. Crossref

  2. Tsivileva Olga M., Pankratov Alexei N., Nikitina Valentina E., Extracellular protein production and morphogenesis of Lentinula edodes in submerged culture, Mycological Progress, 9, 2, 2010. Crossref

  3. Kozarski Maja, Klaus Anita, Jakovljevic Dragica, Todorovic Nina, Niksic Miomir, Vrvic Miroslav M., van Griensven Leo J.L.D., Dietary polysaccharide extracts of Agaricus brasiliensis fruiting bodies: chemical characterization and bioactivities at different levels of purification, Food Research International, 64, 2014. Crossref

  4. Papaspyridi Lefki-Maria, Katapodis Petros, Gonou-Zagou Zacharoula, Kapsanaki-Gotsi Evangelia, Christakopoulos Paul, Growth and biomass production with enhanced β-glucan and dietary fibre contents of Ganoderma australe ATHUM 4345 in a batch-stirred tank bioreactor, Engineering in Life Sciences, 11, 1, 2011. Crossref

  5. . Mahmoud M. Nour El-D, . Amira A. El-Fallal, . EL-Shahat A. Toson, . Faten E. Hereher, Exopolysaccharides Production by Pleurotus pulmonarius: Factors Affecting Formation and Their Structures, Pakistan Journal of Biological Sciences, 7, 6, 2004. Crossref

  6. Poyedinok Natalia, Mykhaylova Oksana, Tugay Tatyana, Tugay Andrei, Negriyko Anatoly, Dudka Irina, Effect of Light Wavelengths and Coherence on Growth, Enzymes Activity, and Melanin Accumulation of Liquid-Cultured Inonotus obliquus (Ach.:Pers.) Pilát, Applied Biochemistry and Biotechnology, 176, 2, 2015. Crossref

  7. Pohleven Jure, Obermajer Nataša, Sabotič Jerica, Anžlovar Sabina, Sepčić Kristina, Kos Janko, Kralj Bogdan, Štrukelj Borut, Brzin Jože, Purification, characterization and cloning of a ricin B-like lectin from mushroom Clitocybe nebularis with antiproliferative activity against human leukemic T cells, Biochimica et Biophysica Acta (BBA) - General Subjects, 1790, 3, 2009. Crossref

  8. Turło J., Gutkowska B., Herold F., Krzyczkowski W., Błażewicz A., Kocjan R., Optimizing vitamin B12 biosynthesis by mycelial cultures of Lentinula edodes (Berk.) Pegl., Enzyme and Microbial Technology, 43, 4-5, 2008. Crossref

  9. Garibay-Orijel Roberto, Córdova Juan, Cifuentes Joaquín, Valenzuela Ricardo, Estrada-Torres Arturo, Kong Alejandro, Integrating wild mushrooms use into a model of sustainable management for indigenous community forests, Forest Ecology and Management, 258, 2, 2009. Crossref

  10. Amal I Hassan, Mona A M Ghoneim, Rasha Y M Ibrahim, Therapeutic role of glucogalactan polysaccharide extracted from Agaricus bisporus on trimethyltin chloride induced neuropathy in rats, African Journal of Biotechnology, 14, 24, 2015. Crossref

  11. Turło Jadwiga, Gutkowska Bożenna, Herold Franciszek, Effect of selenium enrichment on antioxidant activities and chemical composition of Lentinula edodes (Berk.) Pegl. mycelial extracts, Food and Chemical Toxicology, 48, 4, 2010. Crossref

  12. Raja Huzefa A., Baker Timothy R., Little Jason G., Oberlies Nicholas H., DNA barcoding for identification of consumer-relevant mushrooms: A partial solution for product certification?, Food Chemistry, 214, 2017. Crossref

  13. Martins Anabela, The Numbers Behind Mushroom Biodiversity, in Wild Plants, Mushrooms and Nuts, 2016. Crossref

  14. Zjawiony Jordan, Antimicrobial and Antiviral Metabolites from Polypore Fungi, in Novel Therapeutic Agents from Plants, 2009. Crossref

  15. Hassan Mohamed, Rouf Razina, Tiralongo Evelin, May Tom, Tiralongo Joe, Mushroom Lectins: Specificity, Structure and Bioactivity Relevant to Human Disease, International Journal of Molecular Sciences, 16, 12, 2015. Crossref

  16. Li Jing, He Xing, Liu Xiao-Bin, Yang Zhu L., Zhao Zhi-Wei, Species clarification of oyster mushrooms in China and their DNA barcoding, Mycological Progress, 16, 3, 2017. Crossref

  17. Badalyan Susanna M., Barkhudaryan Anush, Rapior Sylvie, Recent Progress in Research on the Pharmacological Potential of Mushrooms and Prospects for Their Clinical Application, in Medicinal Mushrooms, 2019. Crossref

  18. Wong Kah-Hui, Mushroom nutriceuticals in Malaysia, International Journal of Complementary & Alternative Medicine, 11, 2, 2018. Crossref

  19. Minato Ken-ichiro, Mushrooms: Immunomodulating Activity and Role in Health Promotion, in Dietary Components and Immune Function, 2010. Crossref

  20. Thakur Monika, Wild Macro-Fungi from Northwest Himalayas: Future Prospects and Challenges, in Biology of Macrofungi, 2018. Crossref

  21. Kao Chi H. J., Greenwood David R., Jamieson Stephen M. F., Coe Margaret E., Murray Pamela M., Ferguson Lynnette R., Bishop Karen S., Anticancer Characteristics of Fomitopsis pinicola Extract in a Xenograft Mouse Model—a Preliminary Study, Nutrition and Cancer, 72, 4, 2020. Crossref

  22. Naumov Alexander D., Timokhina Natalia I., Litvinchuk Alexandra V., Vereshchako Gennadii G., Khodosovskaya Alina M., Sushko Svetlana N., Kadukova Elena M., Radioprotective Properties of Selenomethionine with Methionine, Extracts from Basidium Fungi and Exogenous DNA, in Advanced Bioactive Compounds Countering the Effects of Radiological, Chemical and Biological Agents, 2013. Crossref

  23. Al Obaydi Maha Farid, Hamed Wafaa M., Al Kury Lina T., Talib Wamidh H., Terfezia boudieri: A Desert Truffle With Anticancer and Immunomodulatory Activities, Frontiers in Nutrition, 7, 2020. Crossref

  24. Xiang Huan, Sun-Waterhouse Dongxiao, Cui Chun, Hypoglycemic polysaccharides from Auricularia auricula and Auricularia polytricha inhibit oxidative stress, NF-κB signaling and proinflammatory cytokine production in streptozotocin-induced diabetic mice, Food Science and Human Wellness, 10, 1, 2021. Crossref

  25. Ravikumar Korattuvalappil S., Ramya Haridas, Ajith Thekkuttuparambil A., Shah Manzoor A., Janardhanan Kainoor K., Bioactive extract of Fomitopsis pinicola rich in 11-α- acetoxykhivorin mediates anticancer activity by cytotoxicity, induction of apoptosis, inhibition of tumor growth, angiogenesis and cell cycle progression, Journal of Functional Foods, 78, 2021. Crossref

  26. Yu Sanhong, Weaver Veronika, Martin Keith, Cantorna Margherita T, The effects of whole mushrooms during inflammation, BMC Immunology, 10, 1, 2009. Crossref

  27. Sheng Feiya, Wang Songsong, Luo Xiao, Xiao Jianbo, Hu Linfeng, Li Peng, Simultaneous determination of ten nucleosides and bases in Ganoderma by micellar electrokinetic chromatography, Food Science and Human Wellness, 11, 2, 2022. Crossref

  28. Ahmadifar Saeideh, Hosseini syed Mohsen, Mohammadi Goltapeh Ebrahim, Jahedi Akbar, Optimal method for production of mycelia biomass of Ganoderma lucidum in sugarcane molasses, Plant Pathology Science, 9, 1, 2020. Crossref

  29. van Steenwijk Hidde P., Bast Aalt, de Boer Alie, Immunomodulating Effects of Fungal Beta-Glucans: From Traditional Use to Medicine, Nutrients, 13, 4, 2021. Crossref

  30. Zjawiony Jordan K., Biologically Active Compounds from Aphyllophorales (Polypore) Fungi, Journal of Natural Products, 67, 2, 2004. Crossref

  31. Tung Yu-Tang, Pan Chun-Hsu, Chien Yi-Wen, Huang Hui-Yu, Edible Mushrooms: Novel Medicinal Agents to Combat Metabolic Syndrome and Associated Diseases, Current Pharmaceutical Design, 26, 39, 2020. Crossref

  32. Ullah Zain, Öztürk Mehmet, Ertaş Abdulselam, Wahab Atia-tul, Ben Mansour Riadh, Iqbal Choudhary M., Insight into isolation and elucidation of cytotoxic ergostanoids from the mushroom Sarcosphaera crassa (Santi) Pouzar: An edible mushroom, Steroids, 181, 2022. Crossref

  33. Reis Filipa S., Martins Anabela, Vasconcelos M. Helena, Morales Patricia, Ferreira Isabel C.F.R., Functional foods based on extracts or compounds derived from mushrooms, Trends in Food Science & Technology, 66, 2017. Crossref

Begell Digital Portal Begellデジタルライブラリー 電子書籍 ジャーナル 参考文献と会報 リサーチ集 価格及び購読のポリシー Begell House 連絡先 Language English 中文 Русский Português German French Spain